Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Scientific Reports|October 29, 2020
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patientsPaola Monti, Marta Lionetti, Giuseppa De Luca, et al.
Oncotarget|June 6, 2015
Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patternsIngrid Cifola, Marta Lionetti, Eva Pinatel, et al.
Plos One|September 8, 2011
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemiaFrancesco Maura, Giovanna Cutrona, Sonia Fabris, et al.
American Journal of Hematology|November 2, 2012
B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemiaFrancesco Maura, Carlo Visco, Erika Falisi, et al.
British Journal of Haematology|March 4, 2014
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implicationsMarta Lionetti, Sonia Fabris, Giovanna Cutrona, et al.
Hepatology (Baltimore, Md.)|March 12, 2024
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver diseaseAlfredo Marchetti, Serena Pelusi, Alessio Marella, et al.
Haematologica|May 15, 2025
Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myelomaAndrea Poletti, Barbara Taurisano, Gaia Mazzocchetti, et al.
Plos One|March 19, 2015
Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemiaFrancesco Maura, Laura Mosca, Sonia Fabris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2014
microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parametersMassimo Negrini, Giovanna Cutrona, Cristian Bassi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2012
Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidenceMaria T Di Martino, Emanuela Leone, Nicola Amodio, et al.
Pageof 7